| Index | — | P/E | 24.37 | EPS (ttm) | 1.66 | Insider Own | — | Shs Outstand | 1.74B | Perf Week | 0.70% |
| Market Cap | 70.22B | Forward P/E | 19.26 | EPS next Y | 2.10 | Insider Trans | — | Shs Float | 1.74B | Perf Month | 21.07% |
| Enterprise Value | 81.72B | PEG | 2.10 | EPS next Q | 1.22 | Short Float | 0.27% | Perf Quarter | 9.95% | ||
| Income | 3.02B | P/S | 5.41 | EPS this Y | 9.38% | Short Ratio | 2.04 | Perf Half Y | 11.28% | ||
| Sales | 12.98B | P/B | 42.25 | EPS next Y | 10.94% | ROA | 15.05% | Short Interest | 4.67M | Perf YTD | 0.10% |
| Book/sh | 0.96 | P/C | — | EPS next 5Y | 11.63% | ROE | 125.53% | 52W High | 44.79 -11.99% | Perf Year | -8.81% |
| Cash/sh | 0.17 | P/FCF | 18.10 | EPS past 3/5Y | 12.17% 12.84% | ROIC | 21.44% | 52W Low | 27.57 42.98% | Perf 3Y | 17.75% |
| Dividend Est. | 0.56 (1.43%) | EV/EBITDA | 15.74 | Sales past 3/5Y | 6.30% 6.78% | Gross Margin | 62.65% | Volatility | 1.84% 1.77% | Perf 5Y | 31.53% |
| Dividend TTM | 0.92 (2.33%) | EV/Sales | 6.30 | EPS Y/Y TTM | 21.76% | Oper. Margin | 31.55% | ATR (14) | 0.86 | Perf 10Y | 124.03% |
| Dividend Ex-Date | Aug 07, 2026 | Quick Ratio | 0.40 | Sales Y/Y TTM | 4.14% | Profit Margin | 23.27% | RSI (14) | 69.64 | Recom | 2.43 |
| Dividend Gr. 3/5Y | 8.84% 7.99% | Current Ratio | 0.45 | EPS Q/Q | 6.28% | SMA20 | 5.90% | Beta | 0.66 | Target Price | 26.00 |
| Payout | 53.40% | Debt/Eq | 7.10 | Sales Q/Q | 3.26% | SMA50 | 12.43% | Rel Volume | 0.85 | Prev Close | 40.46 |
| Employees | 37,000 | LT Debt/Eq | 5.23 | Earnings | Feb 18 | SMA200 | 17.32% | Avg Volume | 2.17M | Price | 39.42 |
| IPO Date | Oct 06, 1994 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 1.84% -1.19% | Net Debt/EBITDA | 2.21 | Volume | 1,848,163 | Change | -2.57% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-20-26 | Downgrade | Citigroup | Buy → Neutral | |
| Apr-08-26 | Upgrade | Citigroup | Neutral → Buy | |
| Mar-14-25 | Upgrade | Barclays | Equal Weight → Overweight | |
| Oct-04-23 | Upgrade | Goldman Sachs | Neutral → Buy | |
| Sep-26-22 | Reiterated | JonesTrading | $28 | |
| May-12-22 | Reiterated | Morgan Stanley | $24 | |
| Mar-05-20 | Upgrade | UBS | Sell → Neutral | |
| Jan-21-20 | Upgrade | Citigroup | Neutral → Buy | |
| Sep-24-18 | Upgrade | Barclays | Equal Weight → Overweight | |
| Feb-12-18 | Downgrade | Barclays | Overweight → Equal Weight |
RELX Plc is a global enterprise that delivers data-driven analytical solutions and strategic decision-making instruments to professional and corporate clients across North America, Europe, and other international markets. Its operations are structured into four distinct divisions: Risk, Scientific, Technical & Medical (STM), Legal, and Exhibitions. The Risk division specializes in providing advanced analytical platforms and decision support systems. These tools leverage a blend of publicly available and industry-specific data, integrated with sophisticated technology and algorithms, to help clients assess and forecast potential risks. Through its Scientific, Technical & Medical unit, RELX furnishes crucial information and analytical insights designed to foster scientific advancement and improve healthcare outcomes for institutions and practitioners alike. The Legal sector provides comprehensive legal, regulatory, and commercial intelligence, alongside analytical capabilities, enabling clients to make informed choices and enhance their operational efficiency. Finally, the Exhibitions division manages a portfolio of events, merging in-person interactions with data-driven and digital resources. This approach assists attendees in exploring market trends, identifying products, and facilitating business transactions. Established in 1903, the company, originally named Reed Elsevier PLC, adopted its current identity, RELX PLC, in July 2015. Its global headquarters are situated in London, United Kingdom.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 12,982 | 12,660 | 12,055 | 11,391 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 4,847 | 4,595 | 4,217 | 3,999 | — | — | — | — | — | |
| Gross Profit | 8,135 | 8,065 | 7,838 | 7,392 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 4,510 | 4,454 | 4,237 | 4,114 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 465 | 410 | — | — | — | — | — | |
| Other Operating Expense | -472 | -327 | -520 | -467 | — | — | — | — | — | |
| Operating Income | 4,097 | 3,938 | 3,656 | 3,335 | — | — | — | — | — | |
| Interest Expense | 251 | 393 | 359 | 373 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 149 | 86 | -29 | -108 | — | — | — | — | — | |
| Net Income Before Taxes | 3,993 | 3,630 | 3,267 | 2,854 | — | — | — | — | — | |
| Income Taxes | 957 | 887 | 783 | 630 | — | — | — | — | — | |
| Consolidated Net Income | 3,022 | 2,726 | 2,471 | 2,215 | — | — | — | — | — | |
| Net Income From Continuing Operations | 3,038 | 2,743 | 2,484 | 2,223 | — | — | — | — | — | |
| Net Income | 3,022 | 2,726 | 2,471 | 2,215 | — | — | — | — | — | |
| EPS (Recurring) | 1.68 | 1.49 | 1.33 | 1.17 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 1.68 | 1.49 | 1.33 | 1.17 | — | — | — | — | — | |
| EPS (Diluted) | 1.66 | 1.48 | 1.32 | 1.17 | — | — | — | — | — | |
| EBITDA | 5,193 | 4,951 | 4,625 | 4,194 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 23.75 | 27.34 | 34.51 | 33.93 | — | — | — | — | — | |
| Price To Sales Ratio | 5.43 | 5.86 | 7.03 | 6.59 | — | — | — | — | — | |
| Gross Margin | 62.66 | 63.70 | 65.02 | 64.89 | — | — | — | — | — | |
| Operating Margin | 31.56 | 31.11 | 30.33 | 29.28 | — | — | — | — | — | |
| Net Margin | 23.28 | 21.53 | 20.50 | 19.45 | — | — | — | — | — | |
| Shares Outstanding | 1,787 | 1,834 | 1,866 | 1,892 | — | — | — | — | — | |
| Market Capitalization | 70,444 | 74,130 | 84,754 | 75,037 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |